Certified by Founder Lodge
Nonacus
United Kingdom - Birmingham, West Midlands
INVESTOR
1 Disclosed Funding Rounds $1,776,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Nonacus is focused on delivering innovative technologies to the genomic healthcare sector through the use of cell free circulating DNA as a non-invasive diagnostic tool. Nonacus was created b
CanSense
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Avtal | $24,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Latent | $80,000,000 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
